Caplin Point Laboratories Limited

NSEI:CAPLIPOINT Rapport sur les actions

Capitalisation boursière : ₹158.1b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Caplin Point Laboratories Gestion

Gestion contrôle des critères 4/4

Le PDG Caplin Point Laboratories' est Sridhar Ganesan, nommé en Mar2015, a un mandat de 9.42 ans. La rémunération annuelle totale est ₹ 8.70M, composée du salaire de 95.4% et des bonus 4.6%, y compris les actions et options de la société. détient directement 0.12% des actions de la société, d'une valeur de ₹ 167.84M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 8.5 ans et 6.1 ans.

Informations clés

Sridhar Ganesan

Directeur général

₹9.3m

Rémunération totale

Pourcentage du salaire du PDG95.7%
Durée du mandat du directeur général9.6yrs
Propriété du PDG0.1%
Durée moyenne d'occupation des postes de direction8.7yrs
Durée moyenne du mandat des membres du conseil d'administration6.3yrs

Mises à jour récentes de la gestion

Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise

Sep 15
Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise

We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Sep 23
We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Recent updates

Caplin Point Laboratories (NSE:CAPLIPOINT) Is Due To Pay A Dividend Of ₹2.50

Sep 12
Caplin Point Laboratories (NSE:CAPLIPOINT) Is Due To Pay A Dividend Of ₹2.50

Earnings Update: Here's Why Analysts Just Lifted Their Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Price Target To ₹1,764

Aug 11
Earnings Update: Here's Why Analysts Just Lifted Their Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Price Target To ₹1,764

Caplin Point Laboratories (NSE:CAPLIPOINT) Is Paying Out A Dividend Of ₹2.50

Aug 10
Caplin Point Laboratories (NSE:CAPLIPOINT) Is Paying Out A Dividend Of ₹2.50

Investors Aren't Buying Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Earnings

Jul 12
Investors Aren't Buying Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Earnings

Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues

May 24
Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues

Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?

May 04
Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement

Mar 07
Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement

With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case

Oct 24
With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case

Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise

Sep 15
Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise

Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50

Aug 11
Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50

We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Sep 23
We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year

Sep 11
Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year

Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?

Jul 22
Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?

Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00

May 15
Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00

A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Jan 21
A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?

Oct 20
Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?

Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50

Sep 17
Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50

Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50

Sep 03
Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price

Aug 27
Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price

Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?

Jun 12
Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?

Estimating The Fair Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Apr 29
Estimating The Fair Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)

Does Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Have A Place In Your Dividend Portfolio?

Mar 24
Does Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Have A Place In Your Dividend Portfolio?

We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt

Mar 11
We Think Caplin Point Laboratories (NSE:CAPLIPOINT) Can Stay On Top Of Its Debt

Do Caplin Point Laboratories's (NSE:CAPLIPOINT) Earnings Warrant Your Attention?

Feb 26
Do Caplin Point Laboratories's (NSE:CAPLIPOINT) Earnings Warrant Your Attention?

Analyse de la rémunération des PDG

Comment la rémunération de Sridhar Ganesan a-t-elle évolué par rapport aux bénéfices de Caplin Point Laboratories?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

₹5b

Mar 31 2024₹9m₹9m

₹5b

Dec 31 2023n/an/a

₹4b

Sep 30 2023n/an/a

₹4b

Jun 30 2023n/an/a

₹4b

Mar 31 2023₹9m₹8m

₹4b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹3b

Jun 30 2022n/an/a

₹3b

Mar 31 2022₹6m₹5m

₹3b

Dec 31 2021n/an/a

₹3b

Sep 30 2021n/an/a

₹3b

Jun 30 2021n/an/a

₹3b

Mar 31 2021₹6m₹5m

₹2b

Dec 31 2020n/an/a

₹2b

Sep 30 2020n/an/a

₹2b

Jun 30 2020n/an/a

₹2b

Mar 31 2020₹6m₹6m

₹2b

Dec 31 2019n/an/a

₹2b

Sep 30 2019n/an/a

₹2b

Jun 30 2019n/an/a

₹2b

Mar 31 2019₹6m₹6m

₹2b

Dec 31 2018n/an/a

₹2b

Sep 30 2018n/an/a

₹2b

Jun 30 2018n/an/a

₹1b

Mar 31 2018₹6m₹6m

₹1b

Rémunération vs marché: La rémunération totale de Sridhar ($USD 103.74K ) est inférieure à la moyenne des entreprises de taille similaire sur le marché Indian ($USD 473.89K ).

Rémunération et revenus: La rémunération de Sridhar a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Sridhar Ganesan (69 yo)

9.6yrs

Titularisation

₹9,300,000

Compensation

Dr. Sridhar Ganesan has been the Managing Director of Caplin Point Laboratories Ltd since March 28, 2015. Dr. Ganesan has been Whole Time Director of Caplin Point Laboratories Ltd since August 25, 2014. He...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Sridhar Ganesan
MD & Whole Time Director9.6yrs₹9.30m0.13%
₹ 205.4m
D. Muralidharan
Chief Financial Officer8.7yrs₹9.10m0.020%
₹ 31.6m
Partheeban Siddarth
Chief Operating Officer13.2yrs₹1.90m11.84%
₹ 18.7b
G. Venkatram
General Counsel2.2yrs₹6.50mpas de données
M. Narayanan
Deputy Chief Financial Officerno datapas de donnéespas de données
Ashok Partheeban
Head of Marketing - Latam Businessno datapas de données11.91%
₹ 18.8b
Thiagaraja Manikandan
Chief Transformation & Digital Officerless than a yearpas de donnéespas de données

8.7yrs

Durée moyenne de l'emploi

Gestion expérimentée: L'équipe de direction de CAPLIPOINT est chevronnée et expérimentée (ancienneté moyenne 8.5 ans).


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Sridhar Ganesan
MD & Whole Time Director10.7yrs₹9.30m0.13%
₹ 205.4m
Paarthipan Chellappan
Non-Executive Non-Independent Chairman34.5yrspas de données18.64%
₹ 29.5b
Damodaran Sathyanarayanan
Non-Executive Independent Director7.9yrs₹160.00kpas de données
Chanderkanta Gariyali
Non-Executive Independent Director4.6yrs₹140.00kpas de données
R. Nagendran
Non-Executive Independent Director2.1yrs₹160.00kpas de données
S. Deenadayalan
Independent Non-Executive Director2.1yrs₹180.00k0.000090%
₹ 142.3k

6.3yrs

Durée moyenne de l'emploi

72yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de CAPLIPOINT sont considérés comme expérimentés (ancienneté moyenne 6.1 ans).